Back
Novo Nordisk AS Vs. MarineMax Industry Stock Comparison
Sell
36
NONOF
Novo Nordisk AS
Last Price:
106.08
Seasonality Move:
8.73%
Buy
64
HZO
MarineMax
Last Price:
32.19
Seasonality Move:
14.85%
Sell
36
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NONOF] share price is $104.51. The Score for NONOF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
MarineMax (HZO)
is a Buy
Is MarineMax a Buy, Sell or Hold?
- The current MarineMax [HZO] share price is $33.39. The Score for HZO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- HZO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $104.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.41 | Sell |
| Relative Strength Index (14 RSI): | 42.8 | Sell |
| Chaikin Money Flow: | -29192 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (103.75 - 112.83) | Sell |
| Bollinger Bands (100): | (112.55 - 135.97) | Sell |
HZO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 62.04 | Buy |
| Chaikin Money Flow: | 210974 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.94 - 31.72) | Buy |
| Bollinger Bands (100): | (29.47 - 34.43) | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 103.53 | Buy |
| 20-day SMA: | 106.58 | Sell |
| 50-day SMA: | 114.7 | Sell |
| 200-day SMA: | 127.62 | Sell |
| 8-day EMA: | 104.36 | Buy |
| 20-day EMA: | 106.98 | Sell |
| 50-day EMA: | 113.81 | Sell |
| 200-day EMA: | 120.2 | Sell |
HZO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.15 | Buy |
| 20-day SMA: | 30.51 | Buy |
| 50-day SMA: | 31.79 | Buy |
| 200-day SMA: | 31.02 | Buy |
| 8-day EMA: | 30.77 | Buy |
| 20-day EMA: | 30.66 | Buy |
| 50-day EMA: | 31.1 | Buy |
| 200-day EMA: | 31.46 | Buy |
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
MarineMax Earnings Growth & HZO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.10 per share, and an increase next year of $0.17 per share.
Novo Nordisk AS Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MarineMax Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||